Similar increase of Gzmb+ CD8+ T cells was also seen in blood and DLN from tumor-bearing mice, but not spleen and other non-draining lymph nodes (NDLN) after DT2216 treatment (Supplementary Fig. 7i). Here, CD8A is linked to neoplasm.